NL-OMON40616已完成4 期
Prevention of renal and bladder damage in children with spina bifida by means of early injections with Botulinum-Toxin-A (Botox): a pilot study. - Early Botox in SB patients.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11(—)
入选标准
- •The study group exists of newborns with MMC who are treated with the standard treatment (CIC and anticholinergics). The minimal age at inclusion is 3 months. This is because of the minimal diameter of the urethra which is necessary for cystoscopy.;The historical control group exists of MMC patients who have not been treated with Botox and who were born between 1998 and 2008.
排除标准
- •The exclusion criteria for the study group are:
- •- Patients with swallowing or breathing problems for which medical treatment is or was necessary.
- •- Muscle diseases such as myasthenia gravis, amyotrophic lateral sclerosis or the Syndrome of Eaton-Lambert.;For the historical group the database of (parents of) patients who object against the use of their medical records for research purposes.
研究者
相似试验
进行中(未招募)
1 期
Prevention of renal and bladder damage in children with spina bifida by means of early injections with Botulinum-Toxin-A (Botox): a pilot study.eurogenic bladder function disease in spina bifida patients.MedDRA version: 16.1Level: LLTClassification code 10030685Term: Open spina bifidaSystem Organ Class: 100000004850MedDRA version: 16.1Level: LLTClassification code 10041531Term: Spina bifida without mention of hydrocephalusSystem Organ Class: 100000004850MedDRA version: 16.1Level: LLTClassification code 10029280Term: Neurogenic bladder, not otherwise specifiedSystem Organ Class: 100000004857EUCTR2013-003842-18-NLErasmus MC
招募中
不适用
Prevention of renal and bladder damage in children with spina bifida by means of early injections with Botulinum-Toxin-A (Botox): a pilot study.Spina BifidaNL-OMON27522Erasmus MC, Dept. Urology10
进行中(未招募)
1 期
Preventing urinary tract infections in infants and young children with probiotic E. coli Nissle: FinNiss- trialrinary tract infectionEUCTR2020-001769-35-FIOulu University Hopsital530
招募中
不适用
Reducing renal function deterioration by means of increasing medication adherence, improving immunosuppressive drug exposure and supporting a healthy lifestyle - an implementation studyRenal transplantationImmunosuppressantsMedication adherencee-HealthPatient participationNL-OMON20914eiden University Medical Center, Leiden, The Netherlands100
已完成
不适用
Reducing renal function deterioration by means of increasing medication adherence, improving immunosuppressive drug exposure and supporting a healthy lifestyle - an implementation study.NL-OMON50600eids Universitair Medisch Centrum100
